Kates M, Mansour AM, Lamm DL, Shore N, et al. Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Non-muscle Invasive Bladder Cancer. J Urol 2022 May 16:101097JU0000000000002778. doi: 10.1097/JU.0000000000002778.
PMID: 35574612